Volitionrx (VNRX) Interest Coverage Ratio Growth (3y) (2021 - 2025)
Volitionrx (VNRX) Interest Coverage Ratio Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | -35.05% |
| 10 | Volitionrx | 90,883.07 | -1.03 Mn | - | 34.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.15% |
| Sep 30, 2025 | 23.41% |
| Jun 30, 2025 | 59.51% |
| Mar 31, 2025 | 2.56% |
| Dec 31, 2024 | 36.99% |
| Sep 30, 2024 | -71.39% |
| Jun 30, 2024 | -16.53% |
| Mar 31, 2024 | -21.34% |
| Dec 31, 2023 | -1.00% |
| Sep 30, 2023 | 31.54% |
| Jun 30, 2023 | 58.55% |
| Mar 31, 2023 | -27.66% |
| Dec 31, 2022 | -5.59% |
| Sep 30, 2022 | 25.94% |
| Jun 30, 2022 | -70.23% |
| Mar 31, 2022 | 22.50% |
| Dec 31, 2021 | -135.91% |
| Sep 30, 2021 | 56.08% |
| Jun 30, 2021 | 61.51% |